Thorell Marella

Chief Financial Officer at Evelo Biosciences, Inc.

Sold, on record
$26k
Dollars the filings state
Form 4 sales
4
Latest Nov 8, 2023
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Evelo Biosciences, Inc.Routine
    May 8 2023

    Sold 38,531 shares at $0.13 ($5k)

    Thorell Marella, Chief Financial Officer

    10b5-1 planSold 29.6% of holdings ($17k position)91,469 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Evelo Biosciences, Inc.Routine
    Aug 8 +92 days

    Sold 2,004 shares at $9.51 ($19k)

    Thorell Marella, Chief Financial Officer

    10b5-1 planSold 18.1% of holdings ($105k position)9,069 shares leftFiling

  3. 3 Form 4 sale Evelo Biosciences, Inc.Routine
    Nov 2 +86 days

    Sold 3,999 shares at $0.33 ($1k)

    Thorell Marella, Chief Financial Officer

    10b5-1 planSold 18.5% of holdings ($7k position)17,570 shares leftFiling

  4. 4 Form 4 sale Evelo Biosciences, Inc.Routine
    Nov 8 +6 days

    Sold 1,811 shares at $0.33 ($598)

    Thorell Marella, Chief Financial Officer

    10b5-1 planSold 7.5% of holdings ($8k position)22,259 shares left0.5x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Thorell Marella
Source
Nov 8, 2023Evelo Biosciences, Inc.Chief Financial OfficerForm 4 sale1,811$5987.5%RoutineSEC
Nov 2, 2023Evelo Biosciences, Inc.Chief Financial OfficerForm 4 sale3,999$1k18.5%RoutineSEC
Aug 8, 2023Evelo Biosciences, Inc.Chief Financial OfficerForm 4 sale2,004$19k18.1%RoutineSEC
May 8, 2023Evelo Biosciences, Inc.Chief Financial OfficerForm 4 sale38,531$5k29.6%RoutineSEC